How Low Semaglutide Prices Might Go: Production Costs and Impact on Worldwide Access

Potential launch prices of generic semaglutide are estimated following patent expiry in 2026.

• The study quantifies the global burden of obesity and type 2 diabetes (T2DM) in countries where generic access may become possible.
• Estimations of launch prices could provide insights into the economic landscape following patent expiry.
• The findings may help in understanding the accessibility of treatments for obesity and T2DM post-2026.

Simplified